Ignite Creation Date:
2024-05-06 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 1:54 PM
Study NCT ID:
NCT04720131
Status:
COMPLETED
Last Update Posted:
2024-01-30
First Post:
2021-01-20
Brief Title:
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Beijing Friendship Hospital
Organization Data
Organization:
Beijing Friendship Hospital
Class:
OTHER
Study ID:
BFH-BTCPD-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing Friendship Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhongtao Zhang
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beijing Friendship Hospital
Old Name:
None
Old Organization:
None